Abstract
Herein we reported the synthesis of a novel series of neocryptolepine(5-methyl-5H-indolo[2,3-b]quinoline) derivatives containing different substituents at C11 using methyl 1H-indole-3-carboxylate and N-methylaniline as starting material. The target 21 compounds were evaluated for their antibacterial activity in vitro against gram-positive bacteria(B. subtilis and S. aureus) and gram-negative bacteria(E.coli and S. typhi). Almost all the tested compounds showed moderate to high activities against the four bacterial strains at the minimum inhibitory concentrations(MICs) of 1—10 μg/mL. The obtained results suggest that part of the novel synthetic neocryptolepine derivatives exhibit significant antibacterial effect against all the tested organisms.
Similar content being viewed by others
References
Butler M. S., J. Nat. Prod., 2004, 67, 2141
Cimanga K., Bruyne T. D., Pieters L., Claeys M., Vlietinck A., Te-trahedron Lett., 1996, 37, 1703
El Sayed I., Ramzy F., William S., El Bahanasawy M., Abdel-Staar M. M., Med. Chem. Res., 2012, 21, 4219
El Sayed I. E., Veken P. V., Dhooghe L., Hostyn S., van Baelen G., Lemière G., Maes B. U. W., Cos P., Maes L., Joossens J., Haemers A., Pieters L., Augustyns K., J. Med. Chem., 2009, 52, 2979
Jonckers T. H. M., van Miert S., Kanyanga C., Bailly C., Colson P., de Pauw-Gillet M. C., van den Heuvel H., Claeys M., Lemiere F., Esmans E. L., Rozenski J., Quirijnen L., Maes L., Dommisse R., Lemière G. L. F., Vlietinck A., Pieters L., J. Med. Chem., 2002, 45, 3497
Lavrado J., Moreira R., Paulo A., Curr. Med. Chem., 2010, 17, 2348
Lu W. J., Świtalska M., Wang L., Yonezawa M., El Sayed I. E., Wietrzyk J., Inokuchi T., Med. Chem. Res., 2013, 22, 4492
Lu W. J., Wicht K. J., Wang L., Imai K., Mei Z. W., Kaiser M., El Sayed I. E., Egan T. J., Inokuchi T., Eur. J. Med. Chem., 2013, 64, 498
Prakash T. P., Perunninakulath S. P., Santosh G. T., Curr. Org. Chem., 2011, 15, 1036
Mei Z. W., Wang L., Lu W. J., Pang C. Q., Maeda T., Peng W., Kaiser M., El Sayed I. E., Inokuchi T., J. Med. Chem., 2013, 56, 1431
Wang N., Imai K., Pang C. Q., Wang M. Q., Yonezawa M., Zhang Y., Nokami J., Inokuchi T., Bull. Chem. Soc. Jpn., 2013, 86, 864
Wang L., Świtalska M., Mei Z. W., Lu W. J., Takahara Y., Feng X. W., Sayed I. E., Wietrzyk J., Inokuchi T., Bioorg. Med. Chem., 2012, 20, 4820
Xu Y. J., Pieters L., Mini. Rev. Med. Chem., 2013, 13, 1056
Paulo A., Pimentel M., Viegas S., Pires I., Duarte A., Cabrita J., Gomes E. T., J. Ethnopharmacol., 1994, 44, 73
Paulo A., Duarte A., Gomes E. T., J. Ethnopharmacol., 1994, 44, 127
Sawer I. M., Brown M. W., Ford J. L., J. Appl. Bacteriol., 1995, 79, 314
Cimanga K., de Bruyne T., Pieters L., Totte J., Tona L., Kambu K., van den Berghe D., Vlietinck A. J., Phytomedicine, 1998, 5, 209
Mills-Robertson F. C., Aboagye F. A., Duker-Eshun G., Kaminta S., Agbeve S., Afr. J. Pharm. Pharmacol., 2009, 3, 476
Mills-Robertson F. C., Tay S. C., Duker-Eshun G., Walana W., Badu K., Ann. Clin. Microbiol. Antimicrob., 2012, 11, 16
Molina A., Vaquero J. J., Garcia-Navio J. L., Alvarez-Builla J., Pascula-Terasa B., Gago F., Rodrigo M. M., Ballestros M., J. Org. Chem., 1996, 61, 5587
Guittat L., Alberti P., Rosu F., van Miert S., Thetiot E., Pieters L., Gabelica V. E., Pauw D., Ottaviani A., Riou J. F., Mergny J. L., Biochimie, 2003, 85, 535
Poole K., J. Pharm. Pharmacol., 2001, 53, 283
Costerton J. W., Cheng K. J., J. Antimicrob. Chemother., 1975, 1, 363 and references cited therein
Cushnie T. P., Lamb A. J., Int. J. Antimicrob. Agents, 2005, 26, 343
El-Essawy F. A., Boshta N. M., Alotaibi M. A., Elsayed M. S., Tara-bees R. E., Saleh A., Res. Chem. Intermed., 2016, 42, 8157
El-Essawy F. A., Boshta N. M., El-Sawaf A. K., Nassar A. A., Kha-lafallah M. S., Chem. Res. Chinese Universities, 2016, 32(6), 967
El Sayed I., El Kosy S. M., Hawata M. A., El Gokha A., Tolan A., Abd El-Sattar M., J. Am. Sci., 2011, 7, 357
Bailly C., Laine W., Baldeyrou B., de Pauw-Gillet M. C., Colson P., Houssier C., Cimanga K., van Miert S., Vlietinck A., Pieters L., Anti-Cancer Drug Des., 2000, 15, 191
Wang L., Lu W. J., Odawara T., Misumi R., Mei Z. W., Peng W., El-Sayed I. E. T., Inokuchi T., J. Heterocyclic. Chem., 2014, 51, 1106
Peczyńska-Czoch W., Pognan F., Kaczmarek Ł., Boratyński J., J. Med. Chem., 1994, 37, 3503
Osiadacz J., PeczynÄska-Czoch W., Kaczmarek O. A., 6th Interna-tional Symposium on Molecular Aspects of Chemotherapy. 9—12 July, 1997, GdanÄsk, Poland
Kaczmarek L., Peczynska-Czoch W., Osiadacz J., Mordarski M., Sokalski W. A., Boratynski J., Marcinkowska E., Glazman-Kusnierczyk H., Radzikowski C., Bioorg. Med. Chem., 1999, 7, 2457
Hsueh P. R., Chang J. C., Teng L. J., Yang P. C., Ho S. W., Hsieh W. C., Luh K. T., J. Clin. Microbiol., 1997, 35, 1021
Acknowledgments
The authors thank Professor Adel El Sayed El Beltagy, Laboratory of Microbiology, El-Menoufia University, and Faculty of Agriculture for performing the antibacterial test.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
40242_2017_6502_MOESM1_ESM.pdf
Using neocryptolepine scaffold as antimicrobial agent: Synthesis and structure-activity relationships of some novel neocryptolepine derivatives
Rights and permissions
About this article
Cite this article
El-Gokha, A.A., Boshta, N.M., Abo Hussein, M.K. et al. Synthesis and structure-activity relationships of novel neocryptolepine derivatives. Chem. Res. Chin. Univ. 33, 373–377 (2017). https://doi.org/10.1007/s40242-017-6502-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-017-6502-6